These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12802033)

  • 21. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 22. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS; Wheat LJ; Cloud GA; Pierce M; Black JR; Bamberger DM; Goldman M; Thomas CJ; Gutsch HM; Moskovitz B; Dismukes WE; Kauffman CA
    Clin Infect Dis; 1999 May; 28(5):1049-56. PubMed ID: 10452633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
    Kalavathy CM; Thomas PA
    Indian J Ophthalmol; 2002 Mar; 50(1):71-2; author reply 72. PubMed ID: 12090098
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
    Ray A
    Indian J Ophthalmol; 2002 Mar; 50(1):70; author reply 72. PubMed ID: 12090097
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
    Rao SK; Fogla R; Padmanabhan P
    Indian J Ophthalmol; 2002 Mar; 50(1):70-1; author reply 72. PubMed ID: 12090096
    [No Abstract]   [Full Text] [Related]  

  • 28. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 29. Decisions about voriconazole versus liposomal amphotericin B.
    Walsh TJ; Lee J; Dismukes WE
    N Engl J Med; 2002 May; 346(19):1499; author reply 1499. PubMed ID: 12000825
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    Whittle AM; Ali S
    Int J Lab Hematol; 2008 Apr; 30(2):173-4. PubMed ID: 18333850
    [No Abstract]   [Full Text] [Related]  

  • 32. [Invasive fungal infection: challenge and choice].
    Weng XH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1441-2. PubMed ID: 16061015
    [No Abstract]   [Full Text] [Related]  

  • 33. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 36. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
    Caselli D; Aricò M; Michelone G; Cavanna C; Nespoli L; Burgio GR
    Microbiologica; 1990 Oct; 13(4):347-51. PubMed ID: 1965007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
    Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of entomophthoromycosis with itraconazole.
    Kabra SK; Jain Y; Sudhin T; Iyer KV; Ninan SA; Seth V
    Indian Pediatr; 1998 Feb; 35(2):163-6. PubMed ID: 9707860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.